Sixteen countries are struggling to contain outbreaks of the deadly illness, and the ability to make more vaccine is limited to its sole manufacturer.
List of drugs that "when medically needed in acute care must be available and used within hours or days of the need or the patient may suffer serious outcomes which may include disability or death." Check the dashboards for the most recent shortages, or at the complete PDF list, updated every week.
Get Resilient Drug Supply updates in your inbox.
As a result of the supply interruptions, 6% of all programs reported negative patient outcomes.
Disease severity climbed significantly from before the pandemic to 2021 and 2022 to 2023 among children younger than 6 months to 1 year.
Health officials are releasing 77,000 more doses, with supply stretched by higher-than-expected demand for the new tool for protecting newborns.
The drug manufacturer said that demand for 100-milligram doses has been higher than anticipated.
The reasons for the shortages include an overreliance on offshore manufacturing, increased demand, and less manufacturing of generic drugs.
The country struggles with low DPT vaccination levels, especially in the outbreak area.
The countries had procured about 916,120 Paxlovid courses, compared with a minimum need for 9,135,953 courses.
The firms analyzed were Cipla, Hikma, Sun Pharma, Teva, and Viatris.
A pediatric hospital system wasted 58,607 antibiotic doses, including drugs in limited US supply.
The failure to follow good manufacturing practices leads to product defects, contamination, and other problems that put patients at risk.